KORU Medical Systems, Inc. (KRMD)
KORU Medical Systems, Inc. specializes in the design, manufacture, and marketing of portable medical devices for ambulatory infusion. Their FREEDOM infusion systems cater to patients requiring subcutaneous therapies across the United States and internationally.
Company Overview
KORU Medical Systems offers innovative ambulatory infusion solutions, capitalizing on the growing demand for convenient and patient-centric medical devices. With its FREEDOM infusion systems and a focus on direct sales and distribution, KRMD is positioned to expand its market share in a niche healthcare segment.
Investment Thesis
KORU Medical Systems presents a compelling investment opportunity within the ambulatory infusion market. The increasing demand for home healthcare and patient-centric medical solutions drives the adoption of KORU's FREEDOM infusion systems. With a market capitalization of $0.23 billion, KRMD offers significant growth potential as it expands its market share through direct sales and strategic partnerships. Key value drivers include continued innovation in infusion technology, expansion into new therapeutic areas, and increasing awareness among healthcare providers and patients. While the company currently operates with a negative profit margin of -9.5%, strategic initiatives to improve operational efficiency and scale production could lead to enhanced profitability. The company's beta of 0.45 suggests lower volatility than the broader market.
Key Highlights
- Market Cap of $0.23B reflects the company's current valuation in the ambulatory infusion market.
- Gross Margin of 62.3% indicates strong pricing power and efficient cost management in manufacturing.
- Beta of 0.45 suggests lower volatility compared to the overall market, potentially appealing to risk-averse investors.
- Focus on ambulatory infusion market aligns with the growing trend of home healthcare and patient-centric solutions.
- Direct sales and distribution network provides greater control over customer relationships and market penetration.
Competitors
Strengths
- Specialized focus on ambulatory infusion systems.
- Proprietary FREEDOM infusion technology.
- Direct sales and distribution network.
- Strong gross margin of 62.3%.
Weaknesses
- Negative profit margin of -9.5%.
- Limited market capitalization of $0.23B.
- Reliance on a niche market segment.
- Potential competition from larger medical device companies.
Catalysts
- Upcoming: Potential FDA approvals for new infusion system applications.
- Ongoing: Expansion of direct sales and marketing efforts.
- Ongoing: Development and launch of next-generation infusion technologies.
- Ongoing: Strategic partnerships and acquisitions to expand market reach.
Risks
- Potential: Regulatory hurdles and compliance costs.
- Potential: Competition from larger medical device companies.
- Potential: Economic downturns affecting healthcare spending.
- Ongoing: Negative profit margin impacting financial stability.
- Ongoing: Reliance on a niche market segment.
Growth Opportunities
- Expansion into New Therapeutic Areas: KORU Medical can leverage its FREEDOM infusion systems to target new therapeutic areas beyond its current focus. This includes exploring applications in pain management, immunology, and oncology, which represent significant market opportunities. By adapting its technology and developing specialized solutions, KORU can diversify its revenue streams and capture a larger share of the infusion market. This expansion could be realized within the next 2-3 years, driving substantial revenue growth.
- Strategic Partnerships and Acquisitions: KORU Medical can pursue strategic partnerships and acquisitions to expand its product portfolio, geographic reach, and market access. Collaborating with pharmaceutical companies or acquiring complementary medical device businesses can accelerate growth and enhance its competitive position. These partnerships can provide access to new technologies, distribution channels, and customer segments, creating synergies and driving long-term value. These partnerships could materialize in the next 1-2 years.
- Increased Focus on Direct Sales and Marketing: KORU Medical can strengthen its direct sales and marketing efforts to increase brand awareness, generate leads, and drive sales. Investing in digital marketing, targeted advertising, and sales force expansion can improve customer engagement and market penetration. By building stronger relationships with healthcare providers and patients, KORU can increase adoption of its FREEDOM infusion systems and capture a larger share of the ambulatory infusion market. This is an ongoing effort that will continually improve.
- International Expansion: KORU Medical has the opportunity to expand its presence in international markets, particularly in Europe and Asia, where there is growing demand for ambulatory infusion solutions. By establishing partnerships with local distributors, obtaining regulatory approvals, and adapting its products to meet local needs, KORU can tap into new revenue streams and diversify its geographic footprint. This expansion could be initiated within the next year, with significant revenue contributions expected in the following years.
- Development of Next-Generation Infusion Technologies: KORU Medical can invest in research and development to create next-generation infusion technologies that offer improved performance, usability, and connectivity. This includes exploring innovations in smart infusion pumps, remote monitoring, and data analytics to enhance patient outcomes and reduce healthcare costs. By staying at the forefront of technological advancements, KORU can maintain its competitive edge and attract new customers. This is an ongoing process that requires continuous investment.
Opportunities
- Expansion into new therapeutic areas.
- Strategic partnerships and acquisitions.
- International market expansion.
- Development of next-generation infusion technologies.
Threats
- Regulatory changes and compliance requirements.
- Technological obsolescence.
- Competition from established medical device companies.
- Economic downturns affecting healthcare spending.
Competitive Advantages
- Proprietary FREEDOM infusion system technology.
- Established relationships with healthcare providers and distributors.
- Focus on patient education and support.
- Brand recognition in the ambulatory infusion market.
About
KORU Medical Systems, Inc., established in 1980 and headquartered in Chester, New York, is dedicated to improving the lives of patients requiring infusion therapy through innovative and portable medical devices. The company designs, manufactures, and markets its FREEDOM infusion systems, which include the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. These systems are primarily used in the ambulatory infusion market, allowing patients to receive treatment outside of a traditional hospital setting. KORU Medical serves both the United States and international markets, distributing its products through a combination of direct sales, medical device distributors, and online channels. The company also places a strong emphasis on education and training, providing resources to clinicians, patients, and patient advocates to ensure proper and effective use of its infusion systems. KORU Medical's commitment to innovation and patient care has established it as a key player in the ambulatory infusion space, addressing the growing need for convenient and accessible medical solutions. The company's gross margin stands at 62.3%.
What They Do
- Designs portable medical devices.
- Manufactures ambulatory infusion systems.
- Markets infusion systems in the United States and internationally.
- Offers FREEDOM60 and FreedomEdge syringe drivers.
- Provides HIgH-Flo subcutaneous safety needle sets.
- Supplies precision flow rate tubing.
- Offers education and training materials.
- Sells products through direct sales, distributors, and online.
Business Model
- Sells portable infusion devices to patients and healthcare providers.
- Generates revenue through direct sales and distribution partnerships.
- Provides training and education services related to its products.
- Focuses on the ambulatory infusion market.
Industry Context
KORU Medical Systems operates within the medical instruments and supplies industry, which is experiencing growth driven by an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. The ambulatory infusion market is a key segment, offering patients greater convenience and flexibility in receiving treatment. The competitive landscape includes companies like HIND, INFU, MXCT, NYXH, and OSUR, which offer various infusion solutions. KORU Medical differentiates itself through its focus on portable, user-friendly devices and a commitment to patient education. The industry is subject to regulatory oversight and technological advancements, requiring companies to continuously innovate and adapt to changing market dynamics.
Key Customers
- Patients requiring subcutaneous infusion therapy.
- Healthcare providers, including doctors and nurses.
- Hospitals and clinics.
- Home healthcare agencies.
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $10M | $-777,970 | $0.00 |
| Q2 2025 | $10M | $-206,870 | $0.00 |
| Q1 2025 | $10M | -$1M | $0.00 |
| Q4 2024 | $9M | -$2M | $0.00 |
Source: Company filings
Chart & Info
Price Chart
KORU Medical Systems, Inc. (KRMD) stock price: $4.74 (+0.00, +0.00%)
Why Bull
- •Recent insider buying suggests confidence in KRMD's future prospects, aligning interests with shareholders.
- •The social trading community shows growing optimism towards KRMD's innovative infusion solutions.
- •Positive market perception of KRMD's expanding market reach in specialized medical treatments.
- •Bullish community sentiment indicates belief in the company's long-term growth potential and strategic direction.
Why Bear
- •Limited analyst coverage may lead to delayed market recognition and price stagnation for KRMD.
- •Bearish community views express concerns about competition from established players in the medical device market.
- •Recent market developments suggest potential headwinds for smaller medical device companies like KRMD.
- •Insider selling, even if for personal reasons, can sometimes trigger negative sentiment and price volatility.
Latest News
-
Down 18.1% in 4 Weeks, Here's Why KORU Medical Systems, Inc. (KRMD) Looks Ripe for a Turnaround
Zacks · Feb 12, 2026
-
Down 18.1% in 4 Weeks, Here's Why KORU Medical Systems, Inc. (KRMD) Looks Ripe for a Turnaround
Yahoo! Finance: KRMD News · Feb 12, 2026
-
Down 18.1% in 4 Weeks, Here's Why KORU Medical Systems, Inc. (KRMD) Looks Ripe for a Turnaround
zacks.com · Feb 12, 2026
-
February 2026's Noteworthy Stocks Estimated Below Intrinsic Value
Yahoo! Finance: KRMD News · Feb 10, 2026
Technical Analysis
Rationale
AI-generated technical analysis for KRMD including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss KORU Medical Systems, Inc. (KRMD) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for KRMD.
Make a Prediction
Set your price target for KORU Medical Systems, Inc. (KRMD), choose a timeframe, and track your prediction accuracy.
Current price: $4.74
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for KRMD.
Price Targets
Wall Street price target analysis for KRMD.
Insider Flow (30d)
MoonshotScore
Score Factors
-
Revenue Growth 4/100
Revenue grew only 18.0% YoY, suggesting the company is in a slower growth phase.
-
Gross Margin 10/100
Gross margin of 62.3% shows excellent pricing power and a strong competitive moat.
-
Operating Leverage 4/100
Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.
-
Cash Runway 5/100
Cash position data is currently unavailable for this company.
-
R&D Intensity 5/100
R&D spending data is currently unavailable for this company.
-
Insider Activity 6/100
No significant insider buying or selling recently, which is neutral for the stock outlook.
-
Short Interest 5/100
Float and volume data unavailable for liquidity analysis.
-
Price Momentum 0/100
No bullish technical signals detected. The stock lacks upward price momentum currently.
-
News Sentiment 5/100
No sentiment data available
What does this score mean?
The MoonshotScore rates KRMD's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Down 18.1% in 4 Weeks, Here's Why KORU Medical Systems, Inc. (KRMD) Looks Ripe for a Turnaround
Down 18.1% in 4 Weeks, Here's Why KORU Medical Systems, Inc. (KRMD) Looks Ripe for a Turnaround
Down 18.1% in 4 Weeks, Here's Why KORU Medical Systems, Inc. (KRMD) Looks Ripe for a Turnaround
February 2026's Noteworthy Stocks Estimated Below Intrinsic Value
Frequently Asked Questions
What does KORU Medical Systems, Inc. do?
KORU Medical Systems, Inc. is a medical device company focused on the design, manufacture, and marketing of portable infusion systems. Their primary product line, the FREEDOM infusion systems, includes syringe drivers, safety needle sets, and flow rate tubing. These systems are used for ambulatory infusion, allowing patients to receive treatment outside of a hospital setting. The company sells its products through direct sales, medical device distributors, and online channels. KORU Medical also provides education and training materials to clinicians, patients, and patient advocates to ensure proper use of its infusion systems.
Is KRMD stock a good buy?
KRMD stock presents a mixed investment profile. The company's strong gross margin of 62.3% indicates efficient cost management, and its focus on the growing ambulatory infusion market offers potential for revenue growth. However, the negative profit margin of -9.5% raises concerns about profitability. Investors should consider the company's growth opportunities, such as expansion into new therapeutic areas and international markets, against the risks of competition and regulatory hurdles. A thorough analysis of the company's financial performance and strategic initiatives is essential before making an investment decision.
What are the main risks for KRMD?
KORU Medical Systems faces several risks, including regulatory changes and compliance costs, competition from larger medical device companies, and economic downturns affecting healthcare spending. The company's negative profit margin poses a financial risk, and its reliance on a niche market segment could limit growth potential. Technological obsolescence is also a concern, requiring continuous innovation to maintain competitiveness. Investors should carefully assess these risks and consider their potential impact on the company's financial performance and market position.
Is KRMD a good stock to buy?
Whether KRMD is a good investment depends on your financial goals, risk tolerance, and investment horizon. Key factors to evaluate include the company's revenue growth trajectory, profit margins, debt-to-equity ratio, competitive moat, and valuation multiples (P/E, P/S, EV/EBITDA) relative to industry peers. Our AI-generated Investment Thesis and SWOT analysis on this page provide a data-driven starting point. Always do your own research and consider consulting a financial advisor before making investment decisions.
What is the KRMD MoonshotScore?
The MoonshotScore for KRMD is an AI-powered rating from 0 to 100 that evaluates a stock across four dimensions: growth potential (revenue and earnings trajectory), financial health (balance sheet strength, cash flow), market momentum (price trends, volume patterns, institutional flows), and risk factors (volatility, debt levels, sector headwinds). Scores above 70 indicate strong potential, 50-70 moderate, and below 50 suggests caution. The score is recalculated daily using the latest financial data and market signals.
How often is KRMD data updated?
KRMD stock prices are updated in real-time during U.S. market hours (9:30 AM - 4:00 PM ET, Monday through Friday). After-hours and pre-market prices are also tracked. Company fundamentals (earnings, revenue, balance sheet) are refreshed when new quarterly or annual reports are filed. Analyst ratings, price targets, and AI-generated insights are updated daily. Breaking news related to KRMD is aggregated continuously from premium financial news sources throughout the day.
What are the growth catalysts for KRMD?
Growth catalysts for KORU Medical Systems, Inc. (KRMD) can include several categories: product catalysts (new launches, FDA approvals, patent grants), financial catalysts (earnings beats, margin expansion, share buybacks), strategic catalysts (acquisitions, partnerships, market expansion into new regions), and macro catalysts (favorable regulation, industry tailwinds, secular growth trends). Our AI analyzes KORU Medical Systems, Inc.'s specific catalysts using earnings transcripts, SEC filings, and news sentiment to identify the most impactful near-term and long-term drivers.
Who are KRMD's main competitors?
KORU Medical Systems, Inc. (KRMD) competes with companies in its industry that target similar customers, markets, or product categories. Competitor analysis involves comparing key metrics: market share, revenue growth rates, profit margins, R&D spending, and valuation multiples. Understanding competitive positioning helps investors assess whether KRMD has a sustainable competitive advantage (moat) through brand strength, network effects, cost leadership, or switching costs. Our Competitors section provides a side-by-side comparison with relevant peers.
What do analysts say about KRMD?
Wall Street analyst coverage for KRMD includes consensus ratings (buy, hold, or sell), 12-month price targets, and earnings estimates. Analyst opinions are aggregated from major investment banks and research firms. Key metrics to watch include the consensus price target (average, high, and low estimates), the number of analysts covering the stock, any recent rating changes (upgrades or downgrades), and how actual earnings compare to analyst estimates (beat or miss history). Our platform aggregates these from multiple data providers for a comprehensive view.
What is KRMD's market cap?
Market capitalization (market cap) for KRMD is calculated by multiplying the current share price by the total number of outstanding shares. It represents the market's total valuation of the company. Stocks are typically categorized as mega-cap ($200B+), large-cap ($10B-$200B), mid-cap ($2B-$10B), small-cap ($300M-$2B), or micro-cap (under $300M). Market cap influences index inclusion, institutional ownership eligibility, and risk profile. Our Key Statistics section shows KRMD's current market cap alongside enterprise value and other valuation metrics.
How has KRMD stock performed recently?
KRMD's recent stock performance can be evaluated across multiple timeframes: daily price changes, week-over-week momentum, monthly trends, and year-to-date returns. Important performance indicators include the stock's 52-week high and low, moving averages (50-day and 200-day SMA), relative strength index (RSI), and volume trends. Comparing KRMD's performance against its sector index and the S&P 500 provides context on whether it is outperforming or underperforming the broader market.
What are the risks of investing in KRMD?
Key risk categories for KRMD include: market risk (overall market downturns affecting stock prices), company-specific risk (management changes, product failures, competitive threats), financial risk (high debt levels, cash burn, dilution from stock issuance), regulatory risk (government policy changes, lawsuits, compliance issues), and macroeconomic risk (interest rate changes, inflation, currency fluctuations). Beta measures KRMD's volatility relative to the market - a beta above 1.0 means higher volatility than the S&P 500. Our AI-generated risk assessment identifies the most relevant risk factors for this specific stock.
Are insiders buying or selling KRMD?
Insider trading activity for KRMD tracks purchases and sales by company executives, directors, and major shareholders (10%+ owners) as reported in SEC Form 4 filings. Insider buying is generally considered a bullish signal because insiders have the deepest knowledge of company operations, while selling may have various motivations (diversification, tax planning, pre-planned 10b5-1 trading plans). Key metrics include the buy-to-sell ratio, total dollar value of insider transactions, and whether multiple insiders are trading in the same direction. Our Insider Flow tab shows recent transactions with dates and dollar amounts.
Is KRMD a good stock for beginners?
KORU Medical Systems, Inc. (KRMD) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.
How risky is KRMD for first-time investors?
Every stock carries risk, including KORU Medical Systems, Inc. (KRMD). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like KRMD.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- Market analysis is based on current industry trends and competitive landscape.
- Growth opportunities and risks are subject to change based on market conditions and company performance.